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Abstract
Background:  Personality traits are conside r e d  r i s k  f a c t o r s  f o r  d r u g  u s e ,  a n d ,  i n  t u r n ,  t h e
psychoactive substances impact individuals' traits. Furthermore, there is increasing interest in
developing treatment approaches that match an individual's personality profile. To advance our
knowledge of the role of individual differences in drug use, the present study compares the
personality profile of tobacco, marijuana, cocaine, and heroin users and non-users using the wide
spectrum Five-Factor Model (FFM) of personality in a diverse community sample.
Method: Participants (N = 1,102; mean age = 57) were part of the Epidemiologic Catchment Area
(ECA) program in Baltimore, MD, USA. The sample was drawn from a community with a wide
range of socio-economic conditions. Personality traits were assessed with the Revised NEO
Personality Inventory (NEO-PI-R), and psychoactive substance use was assessed with systematic
interview.
Results:  Compared to never smokers, current cigarette smokers score lower on
Conscientiousness and higher on Neuroticism. Similar, but more extreme, is the profile of cocaine/
heroin users, which score very high on Neuroticism, especially Vulnerability, and very low on
Conscientiousness, particularly Competence, Achievement-Striving, and Deliberation. By contrast,
marijuana users score high on Openness to Experience, average on Neuroticism, but low on
Agreeableness and Conscientiousness.
Conclusion: In addition to confirming high levels of negative affect and impulsive traits, this study
highlights the links between drug use and low Conscientiousness. These links provide insight into
the etiology of drug use and have implications for public health interventions.
Background
Drug use is related to adverse health and social outcomes
[1]. Cigarette smoking is a leading cause of preventable
disability and death in the U.S. and around the world [2],
increasing the risk of cancer, cardiovascular disease, respi-
ratory and other health problems [3,4]. The use of other
psychoactive substances, most of them illicit drugs, is also
associated with massive social cost beyond the damage to
the individual users, affecting health care, law enforce-
ment, and legal systems [1,5].
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The high individual and social costs of drug use highlight
the need to study factors related to such behaviors. Even if
personality differences between drug users and non-users
are generally small, these effects can have important clin-
ical implications due to the large number of people
involved. Research on the correlates of drug addiction
provides insights for understanding etiology and inform
prevention policies and cessation programs. For example,
from a psychiatric perspective, a number of studies have
documented the high comorbidity of drug use with other
mental disorders [6-10], which indicate that mood, anxi-
ety, and personality disorders need to be considered by
drug treatment specialists to achieve successful interven-
tion. The present study contributes to this line of research
by examining the personality traits associated with current
and lifetime drug use in an economically-diverse commu-
nity sample. Specifically, we attempt to replicate previ-
ously reported associations among personality traits and
smoking status and extend the analyses to users of mari-
juana, heroin, and cocaine. Comparing personality pro-
files, we examine similarities and differences in traits
associated with a variety of drugs used. Although the high
rate of multiple drug use complicates comparisons across
substances, results may point to specific traits that under-
lie the use of a specific drug as well as common factors
across different types of drug use.
The present study adopts the well-validated Five-Factor
Model of personality [11] which comprehensively covers
the five major traits that define human personality across
cultures [12,13]: Neuroticism (N), the tendency to experi-
ence negative emotions such as anxiety and depression;
Extraversion (E), the tendency to be sociable, warm,
active, assertive, cheerful, and in search of stimulation;
Openness to Experience (O), the tendency to be imagina-
tive, creative, unconventional, emotionally and artisti-
cally sensitive; Agreeableness (A), the dimension of
interpersonal relations, characterized by altruism, trust,
modesty, and cooperativeness; and Conscientiousness
(C), a tendency to be organized, strong-willed, persistent,
reliable, and a follower of rules and ethical principles.
Each of these factors is hierarchically defined by specific
facets, which can provide a more in-depth description of
drug users' personalities.
In previous studies, cigarette smokers were found to score
high on facets related to impulsivity and Neuroticism, and
low on Agreeableness and Conscientiousness [14-16].
However, in European and Asian studies and some older
US studies, smokers were also found to score high on
Extraversion [16-18]. Compared to cigarette smoking,
there are fewer studies on the personality correlates of ille-
gal drug use, and these are based on smaller sample sizes
and a variety of personality measures. A meta-analysis
[19] examined personality correlates of marijuana use cat-
egorizing traits into "negative affect" (e.g., depression,
anxiety), "emotionality" (e.g., extraversion, social disinhi-
bition), and "unconventionality" (e.g., tolerance of devi-
ance, non-religiosity). These measures map loosely onto
Neuroticism, Extraversion, and Openness, respectively.
Results suggested that marijuana use was related to high
levels of unconventionality, and only weakly to emotion-
ality and negative affect. Another meta-analysis [20]
examined the role of a wide range of Conscientiousness-
related measures on health risk behaviors. Across studies,
a consistent association was found between marijuana use
(as well as other drug use) and low scores on Conscien-
tiousness-related traits. Cocaine users are characterized by
high scores on Neuroticism-related traits [21,22], such as
depression and impulsivity [23,24], as well as Psychoti-
cism [21,22], a trait related to low Agreeableness and low
Conscientiousness. Finally, studies of heroin users con-
sistently depict them as high on Neuroticism [25-28].
Many studies show an association of heroin use with high
Extraversion and high Psychoticism, but this association
appears to be less robust [26-28]. Inconsistencies in the
association of personality and drug use are due to several
factors, such as differences in the personality measures
used, inadequate sample sizes, and socio-cultural differ-
ences. Most studies use measures that capture only a sub-
set of relevant personality traits, and rarely assess all five
major factors and their facets. Studies are also hampered
by reliance on small convenience samples. This is particu-
larly true for studies on the use of illegal drugs. Further,
with few exceptions, studies have focused on a single sub-
stance at a time, making it difficult to detect common pat-
terns across a range of different drugs. This study extends
previous research by examining multiple types of drug use
in a large population-based sample while utilizing a well-
validated and comprehensive measure of personality that




Participants were drawn from the East Baltimore Epidemi-
ologic Catchment Area Study (Baltimore ECA) [29], a
multidisciplinary study which is based on a probability
sample of 3,481 East Baltimore residents who were ini-
tially interviewed in 1981 and followed up in 1992–98
and in 2004–05. Personality traits were assessed at the
two most recent waves. To maximize the sample size,
cross-sectional analyses were conducted on the last valid
personality assessments (N = 1,102), 80% of which were
obtained in 2004–05. At the time of the personality
assessments, age ranged from 30 to 94 years (M = 56.6; SD
= 12.4), and participants had an average of 12.5 years of
education (SD  = 2.6). About 62% of the sample was
female; 63% were White/Non-Hispanic, 34% were Black/
Non-Hispanic, and 3% other or unknown ethnic group.BMC Psychiatry 2008, 8:22 http://www.biomedcentral.com/1471-244X/8/22
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To screen out cognitively impaired individuals, partici-
pants with Mini Mental State Scores [30] below the cut-off
value of 23 were excluded.
As could be expected, participants who completed the per-
sonality measure at follow-up were those who in 1981
were younger (35 vs. 54 years old; p < .01) and more edu-
cated (12.5 vs. 9.7 years of education; p < .01), as com-
pared to those who did not complete the personality
assessment (because of mortality, sample loss, or subject
refusal). There were no significant differences in the pro-
portion of males and females or ethnic groups (Fisher's
exact test: p > .05).
Drug use assessment and prevalence
Trained interviewers asked questions about substance use
after participants signed the informed consent approved
by the ethics committee. The form assured the confidenti-
ality of the answers, and that those were used for research
purposes only. Participation was voluntary, and subjects
could withdraw at any time. Subjects received $20 after
the interview.
Cigarette smoking status was determined by responses to
interview questions, asking participants whether they had
ever smoked tobacco cigarettes and when they smoked
their last cigarette. Of the 1,088 participants without miss-
ing data, we classified "never smokers" as those who never
smoked (n  = 341), "former smokers" as those who
smoked but not in the last seven days (n = 429), and cur-
rent smokers as those who smoked in the last seven days
(n = 318). Use ranged from fewer than 10 cigarettes (40%)
to over 20 cigarettes a day (16%), with a majority smoking
between 11 and 20 cigarettes a day (44%).
Marijuana use was determined by responses to questions
on whether participants had ever used either marijuana or
hashish, even once, and when they last used marijuana or
hashish. Of the 1044 individuals without missing data,
about 55% of the sample responded that they never tried
marijuana or hashish (n = 576), 36% used it but not in the
past-year (n = 380), and 8% did use it in the last-year (n =
88). Among the past-year current users, about 20% used
marijuana daily or almost daily, about 45% used it from
once or twice a week to once or twice a month, and about
35% used it between once and eleven times a year.
Cocaine use was determined by responses to questions on
whether participants had ever used cocaine (including all
forms of cocaine, such as powder, "crack," freebase, and
coca paste) even once, and when they last used any form
of cocaine. Of the 1094 individuals without missing data,
about 82% had never tried cocaine (n = 896), about 16%
used it but not in the past-year (n = 170), and about 3%
did use it in the last-year (n = 28). Among the past-year
current users, about 14% used cocaine daily or almost
daily, about 43% used it from once or twice a week to
once or twice a month, and about 43% used it between
once and eleven times a year.
Heroin use was determined by responses to questions on
whether participants had ever used heroin, even once, and
when they last used it. Of the 1094 individuals without
missing data, about 93% had never tried heroin (n  =
1023), about 6% used it but not in the past-year (n = 62),
and about 1% used it in the last-year (n = 9). Of the nine
past-year current users, three individuals used heroin daily
or almost daily, two used it from once or twice a week to
once or twice a month, and four used it between once and
eleven times a year. Given the small number of current
heroin users, and given that eight out of nine current her-
oin users were also current cocaine users, and 87% of the
former heroin users were also former or current cocaine
users, we examined the association of personality traits
with cocaine or heroin use. As expected in a population-
based sample, we also found substantial overlap among
the other drugs used. Of the former and current smokers,
52% had also used marijuana, 21% cocaine, and 8% her-
oin. About 78% of current and former marijuana users
had also smoked cigarettes, 40% had used cocaine, and
15% heroin. About 82% of current and former heroin/
cocaine users had also smoked cigarettes and 98% had
used marijuana. Demographic information by drug type
is given in Table 1: Across substances, current users were
younger; males were more likely to use marijuana and
cocaine/heroin, but there were no sex differences in ciga-
rette smoking; African-Americans were more likely to use
substances; and low education was associated with higher
use of substances, with the exception of marijuana.
Personality assessment
Participants completed the self-report questionnaire at
home or at a participating institution. The Revised NEO
Personality Inventory [NEO-PI-R, [31]] consists of 240
items answered on a five-point Likert format ranging from
strongly disagree to strongly agree. The NEO-PI-R assesses 30
facets, six for each dimension of the FFM (see Table 2 for
a listing of the 30 facet scales). Raw scores were standard-
ized as T-scores (M = 50, SD = 10) using combined-sex
adult norms reported in the Manual [31]. The NEO-PI-R
has been translated into several languages and used in
more than 50 cultures [12]. Evidence of convergent and
discriminant validity is presented in the Manual [31], and
a large literature demonstrates cross-observer agreement
and prediction of external criteria such as psychological
well-being, health risk behaviors, educational and occu-
pational achievements, coping mechanisms, and longev-
ity [31,32]. In a previous study [33] we tested the validity
of personality assessment in the ECA sample and foundBMC Psychiatry 2008, 8:22 http://www.biomedcentral.com/1471-244X/8/22
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adequate alpha reliabilities, retest-stability, and factor
structure of the NEO-PI-R scales.
Statistical analyses
All analyses were performed using SPSS 13.0 [34]. For
each drug, we performed a MANCOVA with user status as
the independent variable, personality factors and facets as
the dependent variables, and age, sex, education, and eth-
nicity as covariates. Post-hoc comparisons among never,
former, and current users groups were based on LSD esti-
mates. The assumption of homogeneity of variance was
tested using the Levene statistic, and no large violations
were found. Effect sizes were estimated using partial η2.
According to Cohen [35], η2 values of 0.0099, 0.0588 and
0.1379 correspond to small, medium and large effect
sizes, respectively.
Results
Personality traits and smoking status
Multivariate analyses of covariance controlling for demo-
graphic variables indicated significant personality differ-
ences among smoking status groups (see Table 2).
Compared to never smokers, current smokers scored
higher on Neuroticism and lower on Conscientiousness.
Current smokers scored lower on Agreeableness, but this
difference was not significant after controlling for demo-
graphic variables. Former smokers scored intermediate on
Neuroticism and Conscientiousness. At the facet level,
current smokers were characterized by traits related to the
construct of impulsivity, (i.e., N5:Impulsiveness,
E5:Excitement-Seeking, C5:Self-Discipline, and C6:Delib-
eration) [36]. Smokers as a group were also high on
N3:Depression, N6:Vulnerability, and low in A4:Compli-
ance, C1:Competence, and C3:Dutifulness. Although the
magnitude of the effects is small, the differences among
groups are consistent with the findings from previous
studies [14]. Figure 1 plots the full profile of current
smokers against current users of marijuana and cocaine/
heroin, as well as never user of these substances. The Fig-
ure presents estimated marginal means after partialling
out the demographic covariates. Former users are
excluded.
Personality traits and marijuana use
Compared to never users, current marijuana users scored
higher on Openness and lower on Agreeableness and
Conscientiousness (see Table 3). Former users scored
intermediate on these three factors. On the facet level, cur-
rent marijuana users scored higher on four facets of Open-
ness, particularly Openness to O6:Values and O5:Ideas,
and lower on five facets of Conscientiousness, particularly
C3:Dutifulness and C6:Deliberation. Other interesting
effects for current marijuana users were the high scores on
N2:Angry Hostility, N6:Vulnerability, E4:Activity, and
E5:Excitement Seeking, and the low scores on A4:Compli-
ance, as compared to never users. As depicted in Figure 1,
the profile of current marijuana users is similar to the pat-
tern found among current smokers, especially for the fac-
ets of Conscientiousness.
Personality traits and cocaine/heroin use
Compared to never users, current cocaine/heroin users
scored higher on Neuroticism and lower on Conscien-
tiousness (see Table 4). Former cocaine/heroin users
scored lower on Conscientiousness, but did not differ
from never-users on Neuroticism. On the facet level, cur-
rent users scored high on all facets of Neuroticism, with
large effect sizes (difference larger than one SD) on
N6:Vulnerability, high on E5:Excitement Seeking, low on
A1:Trust, A2:Straightforwardness, and A4:Compliance,
Table 1: Demographic statistics by drug type.
Group N Age Female African-American Education
Never smoker 341 58 64% 30% 12.9
Former smoker 429 59 60% 30% 12.6
Current smoker 318 52 62% 45% 11.9
Marijuana: never-user 576 62 69% 30% 12.1
Marijuana: former-user 380 50 53% 37% 13.0
Marijuana: current-user 88 48 44% 47% 12.4
Cocaine/heroin: never-user 887 59 65% 32% 12.4
Cocaine/heroin: former-user 178 48 46% 39% 12.9
Cocaine/heroin: current-user 29 46 48% 59% 11.9
Total 1102 57 62% 34% 12.5
Note. Mean age and education expressed in years. For age, ethnicity, and education there were significant differences between never, former, and 
current users of cigarettes, marijuana, and cocaine/heroin. Sex differences were seen for marijuana and cocaine/heroin users, but not for cigarette 
smoking.BMC Psychiatry 2008, 8:22 http://www.biomedcentral.com/1471-244X/8/22
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and very low on all facets of Conscientiousness, with dif-
ferences larger than one SD  on C1:Competence,
C4:Achievement Striving, and C6:Deliberation. The pro-
file of cocaine/heroin current users is illustrated in Figure
1, which resembles the pattern seen for current smokers,
but the profile of cocaine/heroin users is more extreme.
Additional analyses indicated that although the few indi-
viduals (n = 9) who used both cocaine and heroin had the
most extreme profile, the individuals who were current
users of cocaine but not heroin also scored significantly
higher on Neuroticism and lower on Conscientiousness
than never users.
Discussion
The associations observed in the Baltimore ECA sample
are consistent with the existing literature, which finds
drug users generally high on measures of negative emo-
tionality or psychopathology and low on Conscientious-
ness [8,9,20,37]. Most previous studies have analyzed a
limited number of traits (often omitting the crucial Con-
scientiousness factor) or focused on a single substance,
making it difficult to integrate the body of evidence across
traits or substances. Using a more integrative approach,
this study indicates that low Conscientiousness and high
Neuroticism are consistently associated with tobacco
smoking, heroin, and cocaine use. Low Conscientiousness
is also characteristic of marijuana users, who are average
on Neuroticism and high on Openness, a trait that distin-
guishes marijuana users from other drug users. The
present study extends the previous literature by assessing
higher-level personality factors as well as lower-level fac-
ets. The association among Neuroticism and tobacco/her-
oin/cocaine use was found for all six facets of
Neuroticism, indicating that multiple aspects of negative
emotionality and psychopathology are involved in this
effect. With the exception of C2:Order, low scores on all
NEO-PI-R profile of current users of tobacco, marijuana, and cocaine/heroin and never users of those substances Figure 1
NEO-PI-R profile of current users of tobacco, marijuana, and cocaine/heroin and never users of those sub-
stances. Plots show estimated marginal means after controlling for age, sex, ethnicity, and education.
 BMC Psychiatry 2008, 8:22 http://www.biomedcentral.com/1471-244X/8/22
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facets of Conscientiousness were associated with drug use.
Although Extraversion showed no association with drug
use on the factor level, facet-level analyses revealed a con-
sistent association between high scores on E5:Excitement-
Seeking and all types of drug use. This finding is not sur-
prising given that, together with N5:Impulsiveness (ina-
bility to resist cravings), C5:Self-Discipline (limited
ability to stay on task), and C6:Deliberation (lack of care-
ful consideration of the consequences of one's actions),
the E5:Excitement-Seeking facet is an aspect of impulsivity
[36]. The selective association between drug use and this
specific Extraversion facet also suggests that inconsistent
findings for Extraversion may be due to Extraversion
measures that differ in their relative emphasis on the
excitement-seeking component.
Cross-sectional association analyses provide limited input
on the cause and effect relation between personality traits
and drug use. Although individual differences in person-
ality traits are particularly stable in adulthood [38-40],
some evidence suggests that substance use influences per-
sonality-related variables [41]. Cigarette smoking contrib-
utes to stress, negative affect states, and the onset of
clinical correlates of Neuroticism, such as anxiety and
depressive disorders [42-44]. Piedmont [45] reported sub-
stantial declines in Neuroticism and increases in Agreea-
bleness and Conscientiousness in a group of
polysubstance abusers following a rehabilitation program
[26] (but see [28]). Consistently, smoking cessation is
associated with lower Neuroticism scores, a lower level of
stress, and lower risk of anxiety disorders [42,44]. Another
Table 2: Mean personality traits for never, former, and current cigarette smokers.
NEO-PI-R scales Never-smokers (n = 341) Former-smokers (n = 429) Current-smokers (n = 318) F Partial η2
Neuroticism 48.9 (.51)a 50.7 (.46)b 51.6 (.55)b 6.9** .013
Extraversion 48.8 (.44) 49.3 (.40) 48.4 (.48) 1.0 .002
Openness 45.6 (.44) 46.4 (.39) 46.5 (.47) 1.2 .002
Agreeableness 50.9 (.49) 50.9 (.44) 49.9 (.52) 1.3 .002
Conscientiousness 49.4 (.52)a 49.0 (.46)a 47.0 (.55)b 5.5** .010
N1: Anxiety 49.7 (.46)a 51.0 (.41)b 51.7 (.50)b 4.7** .009
N2: Angry Hostility 49.5 (.50)a 50.7 (.45)a 52.3 (.54)b 6.9** .013
N3: Depression 49.3 (.57)a 50.8 (.51)a 53.1 (.61)b 10.0** .019
N4: Self-consciousness 48.4 (.52)a 50.1 (.46)b 50.0 (.56)b 3.6* .007
N5: Impulsiveness 48.3 (.48)a 49.8 (.43)b 49.7 (.52)b 3.4* .007
N6: Vulnerability 49.3 (.58)a 50.4 (.52)a 52.7 (.63)b 7.9** .015
E1: Warmth 48.9 (.52) 48.4 (.46) 47.2 (.56) 2.4 .005
E2: Gregariousness 50.5 (.50) 51.0 (.45) 49.7 (.54) 1.7 .003
E3: Assertiveness 50.1 (.51) 49.6 (.46) 49.2 (.55) 0.7 .001
E4: Activity 48.1 (.49) 47.3 (.43) 46.9 (.52) 1.5 .003
E5: Excitement-Seeking 46.9 (.47)a 47.7 (.42)a 49.0 (.50)b 4.4* .008
E6: Positive Emotions 48.9 (.51)a 48.9 (.46)a 47.0 (.55)b 3.9* .007
O1: Fantasy 47.8 (.44) 48.5 (.39) 48.3 (.47) 0.7 .001
O2: Aesthetics 48.3 (.48) 49.4 (.43) 49.4 (.52) 1.7 .003
O3: Feelings 46.7 (.46) 47.6 (.41) 47.0 (.50) 1.2 .002
O4: Actions 45.2 (.50) 46.1 (.45) 46.0 (.54) 1.0 .002
O5: Ideas 46.5 (.48) 46.9 (.43) 48.1 (.52) 2.7 .005
O6: Values 45.0 (.45) 45.6 (.40) 44.6 (.48) 1.4 .003
A1: Trust 47.2 (.53) 46.6 (.47) 46.2 (.57) 0.9 .002
A2: Straightforwardness 50.7 (.50) 51.0 (.44) 50.2 (.53) 0.7 .001
A3: Altruism 50.2 (.52)a 51.6 (.46)b 49.9 (.55)a 3.5* .007
A4: Compliance 50.5 (.55)a 48.8 (.49)b 48.4 (.59)b 3.8* .007
A5: Modesty 50.9 (.50) 51.5 (.45) 51.1 (.54) 0.3 .001
A6: Tender-mindedness 52.0 (.50) 52.4 (.44) 52.2 (.53) 0.2 .000
C1: Competence 50.0 (.56)a 49.9 (.50)a 46.7 (.60)b 10.2** .019
C2: Order 47.5 (.47) 47.0 (.42) 46.8 (.51) 0.5 .001
C3: Dutifulness 49.0 (.51)a 48.5 (.45)a 45.9 (.55)b 9.0** .017
C4: Achievement Striving 49.0 (.55)a 48.4 (.49)a 46.4 (.58)b 5.4** .010
C5: Self-Discipline 48.6 (.55)a 47.7 (.49)a 46.3 (.59)b 3.8* .007
C6: Deliberation 53.5 (.53)a 52.6 (.48)a 50.0 (.57)b 10.1** .019
Note. Estimated marginal means (Standard Errors), statistical tests, and effect sizes computed after controlling for age, sex, ethnicity (black, white), 
and education (n = 1058).
Means with different superscripts differ significantly at p < .05.
* p < .05; ** p < .01BMC Psychiatry 2008, 8:22 http://www.biomedcentral.com/1471-244X/8/22
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set of evidence suggests that personality traits are risk fac-
tors for psychoactive substance use, along with social
environment and life experiences [46,47]. For example, in
long term longitudinal studies, low Conscientiousness in
childhood predicts cigarette smoking in adulthood
[48,49]. Longitudinal studies in Europe also suggest that
high scores on Neuroticism and Extraversion during ado-
lescence increase the likelihood of being a smoker later in
life [18,50]. A common hypothesis is that individuals
with high Neuroticism use drugs to self-medicate [51,52].
Finally, third variables might be responsible for the asso-
ciation of personality and addictive behaviors. For exam-
ple, personality traits and cigarette smoking are both
highly heritable [53,54], and could be influenced by com-
mon genetic factors [37].
Limitations
There are several limitations to consider when interpret-
ing the results. This sample is not representative of the
entire US population, but it was drawn from a probability
sample that included a wide range of socio-economic con-
ditions. There may be some misclassification with the cat-
egories of never, former, and current-users. For example,
some individuals might be reluctant to disclose their illicit
drug use. Some might not recall use in the distant past.
Categorizing current users based on self-reported behav-
ior during the past year might be too broad. There are
marked differences in the frequency and quantity of drug
use, but the relatively small number of users in the present
sample does not allow finer distinctions or the use of
stricter criteria of addiction. However, preliminary analy-
Table 3: Mean personality traits for never, non-current, and current marijuana users.
NEO-PI-R scales Never-user (n = 576) Former user (n = 380) Current user (n = 88) F Partial η2
Neuroticism 50.0 (.42) 50.4 (.50) 50.9 (1.01) 0.4 .001
Extraversion 49.0 (.37) 48.5 (.44) 49.4 (.88) 0.7 .001
Openness 45.5 (.37)a 46.1 (.44)a 48.8 (.88)b 5.5** .011
Agreeableness 51.6 (.40)a 49.6 (.49)b 48.4 (.98)b 6.3** .012
Conscientiousness 49.7 (.43)a 47.0 (.51)b 47.0 (1.03)b 8.0** .016
N1: Anxiety 50.5 (.38) 50.8 (.46) 50.6 (.92) 0.1 .000
N2: Angry Hostility 50.0 (.41)a 51.2 (.50)ab 53.0 (1.00)b 3.9* .008
N3: Depression 50.4 (.47) 51.4 (.57) 51.2 (1.14) 0.7 .001
N4: Self-consciousness 49.2 (.43) 50.0 (.51) 49.1 (1.03) 0.7 .001
N5: Impulsiveness 48.7 (.40) 49.7 (.48) 50.1 (.96) 1.4 .003
N6: Vulnerability 49.6 (.47)a 51.5 (.57)b 52.2 (1.15)b 3.7* .007
E1: Warmth 49.1 (.43)a 47.1 (.52)b 47.1 (1.03)ab 4.2* .008
E2: Gregariousness 50.8 (.41) 50.1 (.50) 50.4 (1.00) 0.5 .001
E3: Assertiveness 49.7 (.42) 49.4 (.51) 50.7 (1.03) 0.7 .001
E4: Activity 47.4 (.40)a 46.9 (.48)a 50.1 (.97)b 4.6* .009
E5: Excitement-Seeking 47.1 (.39)a 48.5 (.47)b 49.9 (.94)b 4.3* .009
E6: Positive Emotions 49.0 (.42) 47.4 (.51) 48.4 (1.02) 2.3 .005
O1: Fantasy 47.9 (.36) 48.5 (.44) 48.9 (.87) 0.8 .001
O2: Aesthetics 48.5 (.40)a 49.0 (.48)a 51.4 (.96)b 3.9* .008
O3: Feelings 46.6 (.38) 47.3 (.46) 48.6 (.92) 1.9 .004
O4: Actions 45.2 (.42)a 45.9 (.50)a 48.1 (1.01)b 3.2* .006
O5: Ideas 47.2 (.40)a 46.2 (.49)a 49.7 (.97)b 5.7** .011
O6: Values 44.0 (.37)a 46.1 (.44)b 46.9 (.89)b 7.9** .015
A1: Trust 47.3 (.43) 46.5 (.52) 44.7 (1.04) 2.7 .005
A2: Straightforwardness 51.4 (.41) 50.0 (.49) 49.2 (.99) 2.9 .006
A3: Altruism 51.4 (.42)a 49.4 (.51)b 50.4 (1.03)ab 3.8* .008
A4: Compliance 50.4 (.45)a 48.2 (.55)b 47.2 (1.10)b 5.4** .011
A5: Modesty 51.9 (.42) 50.7 (.50) 49.5 (1.01) 2.8 .006
A6: Tender-mindedness 52.5 (.41) 51.6 (.50) 52.2 (.99) 1.0 .002
C1: Competence 50.0 (.47)a 47.7 (.56)b 47.1 (1.13)b 5.0** .010
C2: Order 47.6 (.39) 46.5 (.48) 45.9 (.95) 2.1 .004
C3: Dutifulness 49.2 (.42)a 46.2 (.51)b 46.2 (1.01)b 9.8** .019
C4: Achievement Striving 49.0 (.45)a 46.6 (.55)b 46.1 (1.09)b 6.0** .012
C5: Self-Discipline 48.7 (.46)a 46.5 (.55)b 45.6 (1.10)b 5.3** .010
C6: Deliberation 53.2 (.44)a 50.9 (.54)b 49.9 (1.07)b 6.6** .013
Note. Estimated marginal means (Standard Errors), statistical tests, and effect sizes computed after controlling for age, sex, ethnicity (black, white), 
and education (n = 1013).
Means with different superscripts differ significantly at p < .05.
* p < .05; ** p < .01BMC Psychiatry 2008, 8:22 http://www.biomedcentral.com/1471-244X/8/22
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ses using different classification criteria produced similar
results, and the main findings are mostly consistent with
the literature. In addition to self-report ratings, future
studies should use multiple methods for assessing drug
use and personality traits.
Most studies on drug use are conducted in adolescents
and young adults, who are at life stages associated with
the greater use of drugs. We presented data from an older
cohort, which has presumably passed the experimenta-
tion age. While this contributes to the scarce literature on
drug use in later parts of the lifespan, the advantages of a
lifespan perspective come at the cost of having fewer cur-
rent users in this older cohort. In addition, older cohorts
only include the survivors among those who started drug
use early in life, which may introduce attrition and other
biases. A review of the literature [20] suggested that stud-
ies that involve older populations (over the age of 30
years) report weaker association of Conscientiousness-
related traits and drug use.
Finally, some of the findings may be culture-bound [55].
For example, the results for smoking closely replicate the
findings we previously reported from another US cohort
of similar age but different socio-economic status. How-
ever, studies conducted in Europe [50] and Japan [17]
have found Extraversion associated with cigarette smok-
ing [16]. Such differences might reflect the different social
acceptance of smoking across countries.
Table 4: Mean personality traits for never, non-current, and current cocaine/heroin users.
NEO-PI-R scales Never-user (n = 887) Former user (n = 178) Current user (n = 29) F Partial η2
Neuroticism 50.3 (.32)a 49.7 (.73)a 57.6 (1.77)b 8.8** .016
Extraversion 48.5 (.28) 50.0 (.63) 50.7 (1.54) 2.7 .005
Openness 46.1 (.28) 46.7 (.63) 45.1 (1.54) 0.7 .001
Agreeableness 50.8 (.31) 49.9 (.69) 49.2 (1.69) 1.1 .002
Conscientiousness 49.2 (.32)a 46.8 (.73)b 40.3 (1.77)c 14.7** .027
N1: Anxiety 51.0 (.29)a 49.5 (.66)b 54.9 (1.62)c 5.6** .010
N2: Angry Hostility 50.4 (.31)a 51.4 (.71)a 57.9 (1.73)b 9.1** .017
N3: Depression 50.8 (.36)a 51.0 (.82)a 58.5 (1.99)b 7.2** .013
N4: Self-consciousness 49.6 (.32)a 48.5 (.74)a 54.4 (1.80)b 4.9** .009
N5: Impulsiveness 49.0 (.30)a 50.0 (.69)a 54.0 (1.68)b 4.7** .009
N6: Vulnerability 50.5 (.36)a 50.2 (.82)a 61.3 (2.01)b 14.4** .027
E1: Warmth 48.1 (.32) 48.7 (.74) 49.3 (1.80) 0.4 .001
E2: Gregariousness 50.3 (.31) 51.2 (.71) 49.4 (1.74) 0.9 .002
E3: Assertiveness 49.6 (.32) 50.0 (.73) 47.3 (1.78) 1.0 .002
E4: Activity 47.3 (.30) 48.5 (.69) 46.2 (1.69) 1.7 .003
E5: Excitement-Seeking 47.2 (.29)a 50.0 (.66)b 51.0 (1.62)b 8.7** .016
E6: Positive Emotions 48.4 (.32) 48.0 (.73) 45.7 (1.79) 1.2 .002
O1: Fantasy 48.1 (.28) 48.7 (.63) 48.9 (1.53) 0.5 .001
O2: Aesthetics 48.9 (.30) 49.6 (.69) 50.6 (1.68) 0.8 .002
O3: Feelings 47.0 (.29) 47.3 (.66) 48.7 (1.61) 0.5 .001
O4: Actions 45.5 (.31)a 47.5 (.71)b 42.3 (1.74)a 5.4** .010
O5: Ideas 47.2 (.31) 46.8 (.69) 47.6 (1.69) 0.2 .000
O6: Values 44.7 (.28)a 46.9 (.64)b 45.3 (1.55)ab 4.8** .009
A1: Trust 47.1 (.33)a 45.4 (.74)b 42.6 (1.82)b 4.5* .008
A2: Straightforwardness 50.9 (.31)a 50.2 (.70)a 46.5 (1.72)b 3.3* .006
A3: Altruism 50.6 (.32) 50.7 (.73) 52.1 (1.79) 0.4 .001
A4: Compliance 49.4 (.34)a 49.0 (.78) 45.3 (1.91) 2.3 .004
A5: Modesty 51.2 (.32) 51.2 (.72) 52.2 (1.75) 0.2 .000
A6: Tender-mindedness 52.2 (.31) 52.5 (.71) 52.1 (1.72) 0.1 .000
C1: Competence 49.7 (.35)a 47.4 (.79)b 37.0 (1.92)c 22.3** .041
C2: Order 47.2 (.29) 47.1 (.67) 44.3 (1.63) 1.5 .003
C3: Dutifulness 48.3 (.32)a 46.4 (.73)b 42.5 (1.77)c 7.2** .014
C4: Achievement Striving 48.5 (.34)a 46.7 (.77)b 38.1 (1.87)c 15.9** .029
C5: Self-Discipline 48.1 (.34)a 46.1 (.78)b 39.0 (1.91)c 12.6** .023
C6: Deliberation 52.7 (.33)a 51.0 (.75)a 42.1 (1.84)b 16.6** .031
Note. Estimated marginal means (Standard Errors), statistical tests, and effect sizes computed after controlling for age, sex, ethnicity (black, white), 
and education (n = 1062).
Means with different superscripts differ significantly at p < .05.
* p < .05; ** p < .01BMC Psychiatry 2008, 8:22 http://www.biomedcentral.com/1471-244X/8/22
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Conclusions: Clinical and social policy 
implications
Personality traits are associated with the outcome of ther-
apeutic interventions. For example, several studies found
Neuroticism, anxiety, and depressive disorders related to
poor treatment outcome for nicotine dependence [56].
Although we found systematic differences between the
personality profiles of substance users and non-users,
there is substantial variability in both groups (e.g., not all
smokers score high on Neuroticism or low on Conscien-
tiousness). Individual differences among substance abus-
ers can play an important role in the choice of treatment
options [57]. Recently, more attention has been focused
on personality trait effects on the efficacy of different treat-
ment plans [58] to tailor therapeutic interventions to indi-
vidual needs [59,60]. More research is needed to fully
evaluate how personality assessment can be useful in the
choice of treatment plans.
Although individual treatments might reduce the rate of
drug abuse, public policy is an important tool for cigarette
smoking and other drug abuse prevention and cessation.
Because of the low conscientiousness, high impulsivity,
and high emotional vulnerability of most drug users, rely-
ing on an individual's resources, without therapeutic
intervention, may produce limited results. Evidence-
based interventions such as safer injecting environments
are an important adjunct which can reduce drug-related
harm [61]. In the case of cigarette smoking, societal pres-
sure in the form of high taxation, restriction in advertis-
ing, and interdiction of smoking in public places are cost-
effective programs that are reducing the prevalence of
smoking [62].
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